Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.30 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24653357 | 0.95 | AHR (0.33) | AHRALOX5MEN1MAPTKMT2A | |
| SCHEMBL26427845 | 0.94 | AHR (0.31) | AHRALOX5MEN1MAPTKMT2A | |
| SCHEMBL19784416 | 0.92 | MMP12 (0.35) | AHRALOX5MEN1MAPTKMT2A | |
| SCHEMBL25626381 | 0.91 | AHR (0.37) | AHRALOX5MEN1MAPTKMT2A | |
| SCHEMBL25631776 | 0.90 | ALOX5 (0.36) | AHRALOX5MEN1MAPTKMT2A | |
| SCHEMBL25633008 | 0.90 | PLA2G2A (0.32) | AHRALOX5MEN1MAPTKMT2A | |
| SCHEMBL25631854 | 0.88 | PLA2G2A (0.34) | HCRTR1PRKDC | |
| SCHEMBL26428623 | 0.88 | — | — | |
| SCHEMBL25925909 | 0.87 | — | — | |
| SCHEMBL25631795 | 0.86 | PLA2G2A (0.39) | AHRALOX5MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024061804-A1 | AN ELECTROLUMINESCENT DEVICE COMPRISING AN ANODE LAYER, A CATHODE LAYER, A FIRST EMISSION LAYER, A HOLE INJECTION LAYER AND A FIRST HOLE TRANSPORT LAYER THAT COMPRISES A COMPOUND CONTAINING A METAL | NOVALED GMBH (DE) | 2024-03-28 | — | — | WO | disclosed |
| US-20240023426-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT LIGHT EMITTING APPARATUS, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20240023436-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20230371376-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | SFC CO., LTD. (KR) | 2023-11-16 | — | — | US | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230171977-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20230127217-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4119634-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SFC Co., Ltd. (KR) | 2023-01-18 | — | — | EP | disclosed |
| US-20230009458-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-12 | — | — | US | disclosed |
| US-20220416170-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023436-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | EED, EML4, ESR1 | AHR 1866/4885ALOX5 3824/4885MEN1 2300/4885 |
| US-20230371376-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | PPOX, MAP1LC3A, VDAC2 | AHR 64/4885ALOX5 870/4885MEN1 2357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.